Trial Profile
A Combination Trial of Copaxone Plus Estriol in RRMS
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Estriol succinate (Primary) ; Glatiramer acetate
- Indications Multiple sclerosis
- Focus Registrational; Therapeutic Use
- Acronyms Estriol in MS
- 02 Feb 2016 According to a Synthetic Biologics media release, on the basis of findings from an independent third party analysis, the Company has decided to terminate its license and clinical trial agreements relating to Trimesta with the Regents of the University of California.
- 02 Feb 2016 Primary endpoint [Relapse rate (At 2 years)] has not been met, according to a Synthetic Biologics media release
- 02 Feb 2016 Results of an independent third party analysis were published in a Synthetic Biologics media release.